Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T18:12:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:23:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 for the study record. This appears to be a metadata update rather than a change to the core study content.
    Difference
    0.0%
    Check dated 2026-03-20T19:57:01.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No study data or content were changed.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:45.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updates: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:50:32.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T00:01:15.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.